Collectively, the data presented in this study suggest that VLA-4–expressing CLL cells residing in the secondary lymphoid organs can receive BCR-mediated stimuli that are able to induce inside-out VLA-4 activation even in the presence of BTK blockade by ibrutinib. This evidence concerns the gene BTK and B-cell chronic lymphocytic leukemia.